Generex Biotechnology Corporation
GNBTQ
OTC PK
| 04/30/2021 | 01/31/2021 | 10/31/2020 | 07/31/2020 | 04/30/2020 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.68M | 596.00K | 833.60K | 15.50K | 416.60K |
| Total Receivables | 52.30K | 169.50K | 183.90K | 164.90K | 142.00K |
| Inventory | 232.10K | 617.90K | 718.60K | 742.30K | 911.00K |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 509.40K | 389.20K | 306.80K | 332.30K | 623.80K |
| Total Current Assets | 2.47M | 1.77M | 2.04M | 1.25M | 2.09M |
|
|
|||||
| Total Current Assets | 2.47M | 1.77M | 2.04M | 1.25M | 2.09M |
| Net Property, Plant & Equipment | 273.20K | 323.80K | 197.50K | 251.80K | 383.50K |
| Long-term Investments | 34.49M | 34.49M | 34.49M | 34.49M | 38.90M |
| Goodwill | 34.49M | 34.49M | 34.49M | 34.49M | 38.90M |
| Total Other Intangibles | 8.67M | 8.90M | 9.13M | 9.37M | 10.49M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 18.80K | 21.40K | 21.40K | 21.40K | 22.40K |
| Total Assets | 45.92M | 45.51M | 45.89M | 45.38M | 51.90M |
|
|
|||||
| Total Accounts Payable | 40.96M | 39.32M | 33.46M | 23.91M | 21.54M |
| Total Accrued Expenses | 4.66M | 4.40M | 4.15M | 3.91M | 3.68M |
| Short-term Debt | 1.33M | 1.35M | 1.35M | 1.35M | 1.35M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.62M | 10.12M | 9.98M | 10.71M | 11.65M |
| Total Finance Division Other Current Liabilities | 8.50M | 4.50M | 3.50M | 1.50M | 1.50M |
| Total Other Current Liabilities | 8.50M | 4.50M | 3.50M | 1.50M | 1.50M |
| Total Current Liabilities | 64.07M | 59.69M | 52.44M | 41.37M | 39.71M |
|
|
|||||
| Total Current Liabilities | 64.07M | 59.69M | 52.44M | 41.37M | 39.71M |
| Long-Term Debt | 551.60K | 499.50K | 499.80K | 499.70K | 499.50K |
| Short-term Debt | 1.33M | 1.35M | 1.35M | 1.35M | 1.35M |
| Capital Leases | 102.50K | 115.70K | -- | -- | 60.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 25.28M | 40.32M | 24.98M | 11.40M | 10.51M |
| Total Liabilities | 90.01M | 100.62M | 77.92M | 53.27M | 50.78M |
|
|
|||||
| Common Stock & APIC | 422.41M | 420.13M | 418.52M | 429.83M | 427.70M |
| Retained Earnings | -479.50M | -488.72M | -464.64M | -452.06M | -440.39M |
| Treasury Stock & Other | 753.80K | 490.70K | 778.10K | 780.30K | 24.50K |
| Total Common Equity | -56.33M | -68.10M | -45.35M | -21.46M | -12.66M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -56.33M | -68.10M | -45.35M | -21.46M | -12.66M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 12.25M | 12.99M | 13.31M | 13.57M | 13.78M |
| Total Equity | -44.08M | -55.11M | -32.03M | -7.88M | 1.12M |
|
|
|||||
